In the RUNX1-driven transplant experiments, Fbxo11 deficiency led to expansion of RUNX1-mutant clones in the periphery and BM, which would be more consistent with AML transformation than overt marrow failure. The gene discussed is FBXO11; the disease is acute myeloid leukemia.